Recombinant Human Conserved oligomeric Golgi complex subunit 5 (COG5), partial, Homo sapiens (Human), E.coli, N-terminal 10xHis-tagged, 33.8kDa, purity >90% as determined by SDS-PAGE.

Recombinant Human Conserved oligomeric Golgi complex subunit 5 (COG5), partial

Recombinant Human Conserved oligomeric Golgi complex subunit 5 (COG5), partial — recombinant protein from Homo sapiens (Human), expressed in E.coli. Purity >90%.

SKU: BCRECP-000401 Category:
Online Inquiry →

Product Specifications

Product SkuBCRECP-000401
Product DescriptionRecombinant Human Conserved oligomeric Golgi complex subunit 5 (COG5) Protein is expressed from E.coli with N-terminal 10xHis-tagged. It contains 1-257aa. [Accession | Q9UP83].
Uniprot No.Q9UP83
Gene NamesCOG5
PurityGreater than 90% as determined by SDS-PAGE.
Expression SystemE.coli
Expression Region1-257aa
SpeciesHomo sapiens (Human)
Tag InfoN-terminal 10xHis-tagged
Molecular weight33.8kDa
ActivityPlease contact us to obtain bioactivity data.
BufferIf the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.
StorageStore at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Research AreasSignal Transduction

Function

Required for normal Golgi function.

Biological Context

Subcellular Location: Cytoplasm, cytosol; Golgi apparatus membrane (Peripheral membrane protein)
Disease Association: Congenital disorder of glycosylation 2I (CDG2I) : A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments. [The disease is caused by variants affecting the gene represented in this entry]

Product Specifications

Recombinant Human Conserved oligomeric Golgi complex subunit 5 (COG5), partial is a recombinant protein from Homo sapiens (Human), expressed in E.coli, covering amino acids 1-257aa, with N-terminal 10xHis-tagged tag, molecular weight 33.8kDa, purity Greater than 90% as determined by SDS-PAGE.. Suitable for ELISA and Western Blot applications.

Recommended applications depend on the target, product format, and product-specific validation data. Refer to the product datasheet or Certificate of Analysis (CoA), or contact BioCrest Sci for application guidance.

Biological Activity: Please contact us to obtain bioactivity data.

Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

Shipping & Lead Time: Availability, shipping conditions, and estimated lead time are confirmed in the formal quotation or order confirmation based on the product format, destination, and order requirements.

Related products

Protein Biology

Function

Required for normal Golgi function

Subcellular Location

Cytoplasm, cytosol; Golgi apparatus membrane (Peripheral membrane protein)

Disease Association

Congenital disorder of glycosylation 2I (CDG2I) : A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments. [The disease is caused by variants affecting the gene represented in this entry]

Subunit

Component of the conserved oligomeric Golgi complex which is composed of eight different subunits and is required for normal Golgi morphology and localization

Gene: COG5  |  Organism: Homo sapiens  |  Synonyms: 13S Golgi transport complex 90 kDa subunit; Component of oligomeric Golgi complex 5; Golgi transport complex 1
Key Publications

Explore closely related product collections, technology platforms, and custom production resources.

Frequently Asked Questions

How do I order or inquire about this product?

Submit the Online Inquiry form with your required quantity and specifications, or email sales@biocrestsci.com. Available sizes, pricing, stock status, documentation, and estimated lead time are confirmed in the formal quotation.

What is the shipping and delivery time?

Availability, dispatch timing, shipping conditions, and delivery estimates depend on the product format, destination, and order requirements. These details are confirmed in the formal quotation or order confirmation.

How should this product be stored?

Follow the storage and handling instructions in the product-specific datasheet and Certificate of Analysis (CoA). Requirements may vary by product form and formulation; contact BioCrest Sci if product-specific guidance is needed.

What quality controls are performed on your products?

Quality-control data such as identity, purity, endotoxin level, or biological activity are provided only when specified on this product page, the datasheet, or Certificate of Analysis (CoA). Biological activity is not implied unless explicitly stated.

Shopping Cart
Scroll to Top